By examining the effects of PDI-inhibition on the invasiveness of MDA-MB-231 cells using space-restrictive porous inserts, novel mechanistic insights are provided, involving fundamental cell stiffness determinants (e.g., F-actin, IFs, and lamins) that may aid the development of robust therapeutic strategies involving PDI inhibitors for breast cancer treatment. Here, P4HB is linked to breast carcinoma.